Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: Effect of specific activity

British Journal of Cancer

Volumn 73, Issue 10, 1996, Pages 1171-1177

  Vaidyanathan, G ^a   Friedman, H S ^a   Keir, S T ^a   Zalutsky, M R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Meta iodobenzylguanidine; Neuroblastoma; Specific activity

Indexed keywords

GUANIDINE DERIVATIVE; IODINE 131; (3 IODOBENZYL)GUANIDINE; ANTINEOPLASTIC AGENT; IODOBENZENE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; HEART; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; EXPERIMENTAL NEOPLASM; METABOLISM; NUDE MOUSE; TISSUE DISTRIBUTION;

3-IODOBENZYLGUANIDINE; ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; IODOBENZENES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEUROBLASTOMA; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029664597     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.226     Document Type: Article

References (33)

1. ANAGNOSTE B, FREEDMAN LS, GOLDSTEIN M, BROOME J AND FUXE K. (1972). Dopamine-β-hydroxylase activity in mouse neuroblastoma tumours and in cell cultures. Proc. Natl Acad. Sci. USA, 69, 1883-1886.
2. 125l]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO. Cancer Res., 48, 2993-2997.
3. BRUCHELT G, KLINEBIEL T, TREUNER J, BECK J, LODE HN, SEITZ G AND NIETHAMMER D. (1995). Radiolabelled meta-iodobenzylguanidine (mIBG) in diagnosis and therapy of neuroblastoma: results from basic research (review). Int. J. Oncol., 6, 705-712.
4. 131I in neuroblastoma diagnosis and follow-up treatment with a review of the diagnostic results of the international workshop of pediatric oncology held in Rome, September 1986. Med. Ped. Oncol., 15, 181-187.
5. FIELDING SL, FLOWER MA, ACKERY D, KEMSHEAD JT, LASHFORD LS AND LEWIS I. (1991). Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. Eur. J. Nucl. Med., 18, 308-316.
6. GARAVENTA A, GUERRA P, ARRIGHINI A, BERTOLAZZI L, BESTAGNO M, DE BERNARDI B, LANINO E, VILLAVECCHIA GP AND CLAUDIANI F. (1991). Treatment of advanced neuroblastoma with 1-131 meta-iodobenzylguanidine. Cancer. 67, 922-928.
7. 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts. Br. J. Radiol., 67, 573-578.
8. 125I-labeled meta-iodobenzylguanidine. Int. J. Cancer, 45, 1164-1168.
9. HELSON L, DAS SK AND HAJDU SI. (1975). Human neuroblastoma in nude mice. Cancer Res., 35, 2594-2599.
10. JAQUES S, TOBES MC AND SISSON JC. (1987). Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. Cancer Res., 47, 3920-3928.
11. 131I]-Metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Cancer Chemother. Pharmacol., 25, 143-148.
12. LASHFORD LS, HANCOCK JP AND KEMSHEAD JT. (1991). Metaiodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C). Int. J. Cancer, 47, 105-109.
13. MCEWAN AJ, SHAPIRO B, SISSON JC, BEIERWALTES WH AND ACKERT DM. (1985). Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumours. Semin. Nucl. Med., 15, 132-153.
14. MCEWAN AJ, WYETH P AND ACKERY D. (1986). Radioiodinated iodobenzylguanidines for diagnosis and therapy. Appl. Radiat, Isot., 37, 765-775.
15. 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by reverse transcription and polymerase chain reaction. Br. J. Cancer, 70, 97-101.
16. MAIRS RJ, CUNNINGHAM SH, RUSSELL J, ARMOUR A, OWENS J, MCKELLAR K AND GAZE MN. (1995). No-carrier-added iodine 131-MIBG: Evaluation of a therapeutic preparation. J. Nucl. Med., 36, 1088-1095.
17. MANGNER TJ, WU J-I AND WIELAND DM. (1982). Solid-phase exchange radioiodination of aryl iodides. Facilitation by ammonium sulfate. J. Org. Chem., 47, 1484-1488.
18. 131I-MIBG. Med. Ped. Oncol., 15, 157-158.
19. 123I]MIBG in rats. Nucl. Med. Commun., 9, 663-667.
20. MONTALDO PG, LANCIOTTI M, CASALARO A, CORNAGLIA-FERRARIS P AND PONZONI M. (1991). Accumulation of m-iodobenzylguanidine by neuroblastoma cells. Results from independent uptake and storage mechanisms. Cancer Res., 51, 4342-4346.
21. NAKAJO M, SHAPIRO B, COPP J, KALFF V, GROSS MD, SISSON JC AND BEIERWALTES WH. (1983a). The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: Evaluation by scintigraphy. J. Nucl. Med., 24, 672-682.
22. 131I]iodobenzylguanidine (I-131 MIBG) and circulating catccholamines in suspected pheochromocytoma. J. Nucl. Med., 24, 1127-1134.
23. 131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy. In Advances in Neuroblastoma Research 3, Prog. Clin. Biol. Res. Vol. 366. Evans AE, A'Angio GJ, Knudson Jr AG and Seeger RC. (eds) pp. 471-478. Wiley-Liss: New York.
24. SISSON JC, SHAPIRO B, BEIERWALTES WH, GLOWNIAK JV, NAKAJO M, MANGNER TJ, CAREY JE, SWANSON DP, COPP JE, SATTERLEE WG AND WIELAND DM. (1984). Radiopharmaceutical treatment of malignant pheochromocytoma. J. Nucl. Med., 24, 197-206.
25. SMETS LA, LOESBERG C, JANSSEN M, METWALLY EA AND HUISKAMP R. (1989). Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells. Cancer Res., 49, 2941-2944.
26. 211At]astatobenzylguanidine on human neuroblastoma cells. Cancer Res., 54, 5414-5419.
27. TOMAYKO MM, TRICHE TJ, NEWBURGH RW AND REYNOLDS CP. (1988). Induction of catecholamines fluorescence in human neuroblastoma cell lines transplanted into nude mice. In Advances in Neuroblastoma Research 2, Prog. Clin. Biol. Vol. 271. Evans AE, D'Angio GJ, Knudson JrAG and Seeger RC (eds) pp. 307-316. Alan R Liss: New York.
28. 131I-metaiodobenzylguanidine. Med. Ped. Oncol., 15, 220-223.
29. 131I]iodobenzylguanidine. Appl. Radiat. Isot., 44, 621-628.
30. 123I]iodobenzylguanidine. Nucl. Med. Biol., 22, 61-64.
31. 211At]astatobenzylguanidine: Further evaluation of a potential therapeutic agent. Int. J. Cancer, 57, 908-913.
32. WIELAND DM, BROWN LE, ROGERS WL, WORTHINGTON KC, WU J-I, CLINTHORNE NH, OTTO CA, SWANSON DP AND BEIERWALTES WH. (1981). Myocardial imaging with a radioiodinated norepinephrine storage analog. J. Nucl. Med., 22, 22-31.
33. WIELAND DM, MANGNER TJ, INBASEKARAN MN, BROWN LE AND WU J-I. (1984). Adrenal medulla imaging agents: a structure distribution relationship study of radiolabelled aralkylguanidines. J. Med. Chem., 27, 149-155.